Lambo, Monica D.
HRN: 00-65-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2022
CEFUROXIME 1.5GM (VIAL)
10/02/2022
10/02/2022
IV
1.5GM
On Call To OR
For Stat CS - Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes